 Bank of New York Mellon Corp bought a new stake in shares of Mirum Pharmaceuticals NASDAQ:MIRM during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 11,508 shares of the companys stock, valued at approximately 282,000. Bank of New York Mellon Corp owned approximately 0.05 ... 